Biology Reference
In-Depth Information
of recombinant human erythropoietin during submaximal and maximal exercise
. Eur J Appl
Physiol
86: 442-449
41 Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R (2000) Effect of
rhEPO administration on serum levels of sTfR and cycling performance.
Med Sci Sports Exerc
32:
1238-1243
42 Berglund B, Ekblom B (1991) Effect of recombinant human erythropoietin treatment on blood
pressure and some haematological parameters in healthy men.
J Intern Med
229: 125-130
43 Lage JM, Panizo C, Masdeu J, Rocha E (2002) Cyclist's doping associated with cerebral sinus
thrombosis.
Neurology
58: 665
44 Comitato Olimpico Nazionale Italiano (2000)
Progetto “Io non rischio la salute
!” Commissione
Scientifica Antidoping del CONI, Rome, Italy
45 Cazzola M (2000) A global strategy for prevention and detection of blood doping with erythro-
poietin and related drugs.
Haematologica
85: 561-563
46 Catlin DH, Hatton CK, Starcevic SH (1997) Issues in detecting abuse of xenobiotic anabolic
steroids and testosterone by analysis of athletes' urine.
Clin Chem
43:1280-1288
47 Aguilera R, Chapman TE, Starcevic B, Hatton CK, Catlin DH (2001) Performance characteristics
of a carbon isotope ratio method for detecting doping with testosterone based on urine diols:
Controls and athletes with elevated testosterone/epitestosterone ratios.
Clin Chem
47: 292-300
48Wallace JD, Cuneo RC, Baxter R, Orskov H, Keay N, Pentecost C, Dall R, Rosen T, Jorgensen
JO, Cittadini A et al. (1999) Responses of the growth hormone (GH) and insulin-like growth fac-
tor axis to exercise, GH administration, and GH withdrawal in trained adult males: A potential test
for GH abuse in sport.
J Clin Endocrinol Metab
84: 3591-3601
49Union Cycliste Internationale UCI (1997) Lettre aux groupes sportifs.
Lettre a tous les coureurs
7-2
50 Vergouwen PC, Collee T, Marx JJ (1999) Haematocrit in elite athletes.
Int J Sports Med
20:
538-541
51 Marx JJ, Vergouwen PC (1998) Packed-cell volume in elite athletes.
Lancet
352: 451
52 Schumacher YO, Schmid A, Lenz T, Keul J (2001) Blood testing in sports: Hematological profile
of a convicted athlete.
Clin J Sport Med
11: 115-117
53 Saris WH, Senden JM, Brouns F (1998) What is a normal red-blood cell mass for professional
cyclists?
Lancet
352: 1758
54 Videman T, Lereim I, Hemmingsson P, Turner MS, Rousseau-Bianchi MP, Jenoure P, Raas E,
Schonhuber H, Rasko H, Stray-Gundersen J (2000) Changes in hemoglobin values in elite cross-
country skiers from 1987-1999.
Scand J Med Sci Sports
10: 98-102
55 Casoni I, Ricci G, Ballarin E, Borsetto C, Grazzi G, Guglielmini C, Manfredini F, Mazzoni G,
Patracchini M, De Paoli Vitali E et al. (1993) Hematological indices of erythropoietin administra-
tion in athletes.
Int J Sports Med
14: 307-311
56 Gareau R, Audran M, Baynes RD, Flowers CH, Duvallet A, Senecal L, Brisson GR (1996)
Erythropoietin abuse in athletes.
Nature
380: 113
57 Audran M, Gareau R, Matecki S, Durand F, Chenard C, Sicart MT, Marion B, Bressolle F (1999)
Effects of erythropoietin administration in training athletes and possible indirect detection in dop-
ing control.
Med Sci Sports Exerc
31: 639-645
58 Parisotto R, Wu M, Ashenden MJ, Emslie KR, Gore CJ, Howe C, Kazlauskas R, Sharpe K, Trout
GJ, Xie M (2001) Detection of recombinant human erythropoietin abuse in athletes utilizing
markers of altered erythropoiesis.
Haematologica
86: 128-137
59 International Olympic Committee (2000) Scientific Green Light for EPO Test.
http://www.olympic.org/uk/news/publications/press/uk.asp?release=56
. International Olympic
Committee, Lausanne, Switzerland. Accessed 10-20-2002
60 Kazlauskas R, Howe C, Trout G (2002) Strategies for rhEPO detection in sport.
Clin J Sport Med
12: 229-235
61 Souillard A, Audran M, Bressolle F, Gareau R, Duvallet A, Chanal JL (1996) Pharmacokinetics
and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and
doping control.
Br J Clin Pharmacol
42: 355-364
62 Flaharty KK, Caro J, Erslev A, Whalen JJ, Morris EM, Bjornsson TD, Vlasses PH (1990)
Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy
men.
Clin Pharmacol Ther
47: 557-564
63 Remacha AF, Ordonez J, Barcelo MJ, Garcia-Die F, Arza B, Estruch A (1994) Evaluation of ery-
thropoietin in endurance runners.
Haematologica
79: 350-352
